IQVIA Q4 FY25: where the revenue came from and where it went
The whole income statement of IQVIA for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Oct 1 – Dec 31, 2025
- Reported
- Feb 17, 2026
Revenue$4.36B
+10% year over year
Gross profit$1.44B
33% margin
Operating profit$0.63B
14% margin
Net profit$0.51B
12% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 4.36 | 100% | +10% |
| Research & development | 2.33 | 53% | +10% |
| Technology & analytics | 1.82 | 42% | +10% |
| Contract sales & medical | 0.21 | 5% | +19% |
| Cost of revenue | −2.93 | 67% | |
| Gross profit | 1.44 | 33% margin | −2pp |
| SG&A | −0.47 | 11% | −1pp |
| Other | −0.34 | 8% | +0pp |
| Operating profit | 0.63 | 14% margin | −1pp |
| Interest & other costs | −0.05 | ||
| Tax | −0.06 | ||
| Net profit | 0.51 | 12% margin | +1pp |
357 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest